Reliability of IUS in Crohn's Disease
- Conditions
- Crohn Disease (CD)
- Registration Number
- NCT06833450
- Lead Sponsor
- Centre Hospitalier Universitaire, Amiens
- Brief Summary
Transabdominal intestinal ultrasound (IUS) is gaining acceptance as a point-of-care test to objectively assess disease activity in Crohn's disease (CD).
In order to incorporate individual parameters in a future definition of transmural healing, and for the consistent application of IUS as a modality to assess treatment outcomes and establish therapeutic targets to ensure comparability between future studies, the inter-observer agreement should be determined for all relevant parameters.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 30
- Crohn's disease evolving for at least 1 months
- Patient older than 18 years
- Patient covered by French national health insurance
- Written informed consent
- Pregnant women or breastfeeding
- Minor
- Patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Number of different IUS parameters between two operators 1 year To assess in patients with CD the variability of IUS parameters between two operators
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
CHU d'Amiens
🇫🇷Amiens, France